Exagen Inc reports results for the quarter ended in March - Earnings Summary

Exagen

12/05/2021 24:41

* Exagen Inc  XGN.OQ  reported a quarterly adjusted loss of 48
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 47
cents per share.
* Revenue rose 10.5% to $10.59 million from a year ago; 
analysts expected $10.45 million. 
* Exagen Inc's reported EPS for the quarter was a loss of 48
cents​.
* The mean earnings estimate of analysts had fallen by
about 13.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Exagen Inc shares had fallen by 13.3% this quarter and
gained 14.9% so far this year.
* The company reported a quarterly loss of $6.21 million.
* Wall Street's median 12-month price target for Exagen Inc is
$25.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 11:41 p.m. GMT.
​All figures in US dollars